Publications 2024

Papantoniou D, Fröss-Baron K, Garske-Román U, Sundin A, Thiis-Evensen E, Grönberg M, Welin S, Tiensuu Janson E (2024)
Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
J Neuroendocrinol, e13379 (in press)
DOI 10.1111/jne.13379, PubMed 38477040

Publications 2023

Edfeldt K, Hellman P, Granberg D, Lagergren P, Thiis-Evensen E, Sundin A, Andersson C (2023)
Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours
J Neuroendocrinol, 35 (10), e13342
DOI 10.1111/jne.13342, PubMed 37807573

Nesti C, Bräutigam K, Benavent M, Bernal L, Boharoon H, Botling J, Bouroumeau A, Brcic I, Brunner M, Cadiot G, Camara M, Christ E, Clerici T, Clift AK, Clouston H, Cobianchi L, Ćwikła JB, Daskalakis K, Frilling A, Garcia-Carbonero R, Grozinsky-Glasberg S, Hernando J, Hervieu V, Hofland J, Holmager P et al. (2023)
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study
Lancet Oncol, 24 (2), 187-194
DOI 10.1016/S1470-2045(22)00750-1, PubMed 36640790

Papantoniou D, Grönberg M, Thiis-Evensen E, Sorbye H, Landerholm K, Welin S, Tiensuu Janson E (2023)
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
Endocr Relat Cancer, 30 (3)
DOI 10.1530/ERC-22-0316, PubMed 36629395

Thiis-Evensen E, Boyar Cetinkaya R (2023)
Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021
J Neuroendocrinol, 35 (4), e13264
DOI 10.1111/jne.13264, PubMed 36988112

Publications 2022

Eshmuminov D, Studer DJ, Lopez Lopez V, Schneider MA, Lerut J, Lo M, Sher L, Musholt TJ, Lozan O, Bouzakri N, Sposito C, Miceli R, Barat S, Morris D, Oehler H, Schreckenbach T, Husen P, Rosen CB, Gores GJ, Masui T, Cheung TT, Kim-Fuchs C, Perren A, Dutkowski P, Petrowsky H et al. (2022)
Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal
Ann Surg, 277 (5), e1063-e1071
DOI 10.1097/SLA.0000000000005663, PubMed 35975918

Knudsen MD, Kvaerner AS, Botteri E, Holme Ø, Hjartåker A, Song M, Thiis-Evensen E, Randel KR, Hoff G, Berstad P (2022)
Lifestyle predictors for inconsistent participation to fecal based colorectal cancer screening
BMC Cancer, 22 (1), 172
DOI 10.1186/s12885-022-09287-9, PubMed 35168592

Thiis-Evensen E (2022)
Letter to the Editor: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
World J Surg, 47 (4), 1083
DOI 10.1007/s00268-022-06873-7, PubMed 36566298

Thiis-Evensen E, Kjellman M, Knigge U, Gronbaek H, Schalin-Jäntti C, Welin S, Sorbye H, Del Pilar Schneider M, Belusa R, Nordic NET Biomarker Group (2022)
Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors
J Neuroendocrinol, 34 (7), e13176
DOI 10.1111/jne.13176, PubMed 35829662

Publications 2021

Janson ET, Knigge U, Dam G, Federspiel B, Grønbaek H, Stålberg P, Langer SW, Kjaer A, Arola J, Schalin-Jäntti C, Sundin A, Welin S, Thiis-Evensen E, Sorbye H (2021)
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Acta Oncol, 60 (7), 931-941
DOI 10.1080/0284186X.2021.1921262, PubMed 33999752

Publications 2020

Kjellman M, Knigge U, Welin S, Thiis-Evensen E, Gronbaek H, Schalin-Jäntti C, Sorbye H, Joergensen MT, Johanson V, Metso S, Waldum H, Søreide JA, Ebeling T, Lindberg F, Landerholm K, Wallin G, Salem F, Schneider MDP, Belusa R (2020)
A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors
Neuroendocrinology, 111 (9), 840-849
DOI 10.1159/000510483, PubMed 32721955

Knudsen MD, Botteri E, Holme Ø, Hjartåker A, Song M, Thiis-Evensen E, Norvard ER, Schult AL, Randel KR, Hoff G, Berstad P (2020)
Association between lifestyle and site-specific advanced colorectal lesions in screening with faecal immunochemical test and sigmoidoscopy
Dig Liver Dis, 53 (3), 353-359
DOI 10.1016/j.dld.2020.11.021, PubMed 33309513

Sorbye H, Meyer LS, Mordal KE, Myhre S, Thiis-Evensen E (2020)
Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours
Health Qual Life Outcomes, 18 (1), 188
DOI 10.1186/s12955-020-01452-7, PubMed 32546236

Thiis-Evensen E, Poole AC, Nguyen HT, Sponheim J (2020)
Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease
BMC Cancer, 20 (1), 466
DOI 10.1186/s12885-020-06963-6, PubMed 32448245

Publications 2019

Dam G, Grønbæk H, Sorbye H, Thiis Evensen E, Paulsson B, Sundin A, Jensen C, Ebbesen D, Knigge U, Tiensuu Janson E (2019)
Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors
Neuroendocrinology, 110 (3-4), 217-224
DOI 10.1159/000503833, PubMed 31578011

Fazio N, Martini JF, Croitoru AE, Schenker M, Li S, Rosbrook B, Fernandez K, Tomasek J, Thiis-Evensen E, Kulke M, Raymond E (2019)
Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumors
Future Oncol, 15 (17), 1997-2007
DOI 10.2217/fon-2018-0934, PubMed 31084373

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, Ricanek P, Vatn S, Moen AEF, Tannæs TM, Lindstrøm JC, Söderholm JD, Halfvarson J, Gomollón F, Casén C, Karlsson MK, Kalla R, Adams AT, Satsangi J, Perminow G (2019)
Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome
Clin Exp Gastroenterol, 12, 37-49
DOI 10.2147/CEG.S186235, PubMed 30774408

Vyakaranam AR, Crona J, Norlén O, Granberg D, Garske-Román U, Sandström M, Fröss-Baron K, Thiis-Evensen E, Hellman P, Sundin A (2019)
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE
Cancers (Basel), 11 (7)
DOI 10.3390/cancers11070909, PubMed 31261748

Publications 2018

Løitegård T, Berntzen DT, Thiis-Evensen E (2018)
The RECIST criteria compared to conventional response evaluation after peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms
Ann Nucl Med, 33 (3), 147-152
DOI 10.1007/s12149-018-1316-2, PubMed 30406360

Raymond E, Kulke MH, Qin S, Yu X, Schenker M, Cubillo A, Lou W, Tomasek J, Thiis-Evensen E, Xu JM, Croitoru AE, Khasraw M, Sedlackova E, Borbath I, Ruff P, Oberstein PE, Ito T, Jia L, Hammel P, Shen L, Shrikhande SV, Shen Y, Sufliarsky J, Khan GN, Morizane C et al. (2018)
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
Neuroendocrinology, 107 (3), 237-245
DOI 10.1159/000491999, PubMed 29991024

Publications 2017

Boyar Cetinkaya R, Aagnes B, Myklebust TÅ, Thiis-Evensen E (2017)
Survival in neuroendocrine neoplasms; A report from a large Norwegian population-based study
Int J Cancer, 142 (6), 1139-1147
DOI 10.1002/ijc.31137, PubMed 29082524

Publications 2016

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Perminow G (2016)
Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy
Scand J Gastroenterol, 52 (4), 414-419
DOI 10.1080/00365521.2016.1259653, PubMed 27887202

Publications 2015

Boyar Cetinkaya R, Aagnes B, Thiis-Evensen E, Tretli S, Bergestuen DS, Hansen S (2015)
Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010
Neuroendocrinology, 104 (1), 1-10
DOI 10.1159/000442207, PubMed 26562558

Zahid W, Bergestuen D, Haugaa KH, Ueland T, Thiis-Evensen E, Aukrust P, Fosse E, Edvardsen T (2015)
Myocardial Function by Two-Dimensional Speckle Tracking Echocardiography and Activin A May Predict Mortality in Patients with Carcinoid Intestinal Disease
Cardiology, 132 (2), 81-90
DOI 10.1159/000431076, PubMed 26111973

Publications 2014

Boyar Cetinkaya R, Vatn M, Aabakken L, Bergestuen DS, Thiis-Evensen E (2014)
Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
Scand J Gastroenterol, 49 (6), 734-41
DOI 10.3109/00365521.2014.903432, PubMed 24679166

Janson ET, Sorbye H, Welin S, Federspiel B, Grønbæk H, Hellman P, Ladekarl M, Langer SW, Mortensen J, Schalin-Jäntti C, Sundin A, Sundlöv A, Thiis-Evensen E, Knigge U (2014)
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Acta Oncol, 53 (10), 1284-97
DOI 10.3109/0284186X.2014.941999, PubMed 25140861

Olbjørn C, Nakstad B, Småstuen MC, Thiis-Evensen E, Vatn MH, Perminow G (2014)
Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients
Scand J Gastroenterol, 49 (12), 1425-31
DOI 10.3109/00365521.2014.966316, PubMed 25310799

Vedeld HM, Andresen K, Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO, Boberg KM, Lind GE (2014)
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
Int J Cancer, 136 (4), 844-53
DOI 10.1002/ijc.29039, PubMed 24948044

Publications 2013

Gedde-Dahl M, Thiis-Evensen E, Tjølsen AM, Mordal KS, Vatn M, Bergestuen DS (2013)
Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
Endocr Connect, 2 (1), 50-4
DOI 10.1530/EC-12-0077, PubMed 23781318

Thiis-Evensen E, Kalager M, Bretthauer M, Hoff G (2013)
Long-term effectiveness of endoscopic screening on incidence and mortality of colorectal cancer: A randomized trial
United European Gastroenterol J, 1 (3), 162-8
DOI 10.1177/2050640613483290, PubMed 24917955

Publications 2012

Ahmed D, Danielsen SA, Aagesen TH, Bretthauer M, Thiis-Evensen E, Hoff G, Rognum TO, Nesbakken A, Lothe RA, Lind GE (2012)
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors
Clin Transl Gastroenterol, 3 (12), e27
DOI 10.1038/ctg.2012.21, PubMed 23324654

Berstad P, Thiis-Evensen E, Vatn MH, Almendingen K (2012)
Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients
J Oncol, 2012, 254801
DOI 10.1155/2012/254801, PubMed 23319946

Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U (2012)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study
Ann Oncol, 24 (1), 152-60
DOI 10.1093/annonc/mds276, PubMed 22967994

Publications 2011

Danielsen SA, Cekaite L, Ågesen TH, Sveen A, Nesbakken A, Thiis-Evensen E, Skotheim RI, Lind GE, Lothe RA (2011)
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome
PLoS One, 6 (9), e24419
DOI 10.1371/journal.pone.0024419, PubMed 21909432

Haugaa KH, Bergestuen DS, Sahakyan LG, Skulstad H, Aakhus S, Thiis-Evensen E, Edvardsen T (2011)
Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease
J Am Soc Echocardiogr, 24 (6), 644-50
DOI 10.1016/j.echo.2011.02.009, PubMed 21440415

Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G, Bretthauer M, Thiis-Evensen E, Nesbakken A, Lothe RA (2011)
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
Mol Cancer, 10, 85
DOI 10.1186/1476-4598-10-85, PubMed 21777459

Lind GE, Raiborg C, Danielsen SA, Rognum TO, Thiis-Evensen E, Hoff G, Nesbakken A, Stenmark H, Lothe RA (2011)
SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis
Oncogene, 30 (37), 3967-78
DOI 10.1038/onc.2011.109, PubMed 21499309

Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, Fetveit T, Vatn MH, Hovig E, Nesbakken A, Lothe RA, Skotheim RI (2011)
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
Genes Immun, 12 (8), 653-62
DOI 10.1038/gene.2011.43, PubMed 21716316

Publications 2010

Berg M, Agesen TH, Thiis-Evensen E, INFAC-study group, Merok MA, Teixeira MR, Vatn MH, Nesbakken A, Skotheim RI, Lothe RA (2010)
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci
Mol Cancer, 9, 100
DOI 10.1186/1476-4598-9-100, PubMed 20459617

Berg M, Danielsen SA, Ahlquist T, Merok MA, Ågesen TH, Vatn MH, Mala T, Sjo OH, Bakka A, Moberg I, Fetveit T, Mathisen Ø, Husby A, Sandvik O, Nesbakken A, Thiis-Evensen E, Lothe RA (2010)
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset
PLoS One, 5 (11), e13978
DOI 10.1371/journal.pone.0013978, PubMed 21103049

Bergestuen DS, Edvardsen T, Aakhus S, Ueland T, Oie E, Vatn M, Aukrust P, Thiis-Evensen E (2010)
Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis
Neuroendocrinology, 92 (3), 168-77
DOI 10.1159/000318014, PubMed 20720391

Bergestuen DS, Gravning J, Haugaa KH, Sahakyan LG, Aakhus S, Thiis-Evensen E, Øie E, Aukrust P, Attramadal H, Edvardsen T (2010)
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors
BMC Cancer, 10, 6
DOI 10.1186/1471-2407-10-6, PubMed 20053285

Janson ET, Sørbye H, Welin S, Federspiel B, Grønbaek H, Hellman P, Mathisen O, Mortensen J, Sundin A, Thiis-Evensen E, Välimäki MJ, Oberg K, Knigge U (2010)
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Acta Oncol, 49 (6), 740-56
DOI 10.3109/0284186X.2010.492791, PubMed 20553100

Publications 2009

Bergestuen DS, Aabakken L, Holm K, Vatn M, Thiis-Evensen E (2009)
Small intestinal neuroendocrine tumors: prognostic factors and survival
Scand J Gastroenterol, 44 (9), 1084-91
DOI 10.1080/00365520903082432, PubMed 19572232

Holme O, Thiis-Evensen E, Vatn MH (2009)
Treatment of fulminant ulcerative colitis with cyclosporine A
Scand J Gastroenterol, 44 (11), 1310-4
DOI 10.3109/00365520903222673, PubMed 19891581

Publications 2008

Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA (2008)
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
Mol Cancer, 7, 94
DOI 10.1186/1476-4598-7-94, PubMed 19117505

Lind GE, Ahlquist T, Kolberg M, Berg M, Eknaes M, Alonso MA, Kallioniemi A, Meling GI, Skotheim RI, Rognum TO, Thiis-Evensen E, Lothe RA (2008)
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis
J Transl Med, 6, 13
DOI 10.1186/1479-5876-6-13, PubMed 18346269

Publications 2006

Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA (2006)
ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis
Cell Oncol, 28 (5-6), 259-72
DOI 10.1155/2006/949506, PubMed 17167179

Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA (2006)
ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis
Cell. Oncol., 28 (5-6), 259-272

Thiis-Evensen E, Seip B, Vatn MH, Hoff GS (2006)
Impact of a colonoscopic screening examination for colorectal cancer on later utilization of distal GI endoscopies
Gastrointest Endosc, 64 (6), 948-54
DOI 10.1016/j.gie.2006.08.006, PubMed 17140903

Publications 2005

Bretthauer M, Lynge AB, Thiis-Evensen E, Hoff G, Fausa O, Aabakken L (2005)
Carbon dioxide insufflation in colonoscopy: safe and effective in sedated patients
Endoscopy, 37 (8), 706-9
DOI 10.1055/s-2005-870154, PubMed 16032487

Publications 2004

Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH (2004)
Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT)
Gut, 53 (9), 1329-33
DOI 10.1136/gut.2004.039032, PubMed 15306594

Publications 2003

Bretthauer M, Hoff GS, Thiis-Evensen E, Huppertz-Hauss G, Skovlund E (2003)
Air and carbon dioxide volumes insufflated during colonoscopy
Gastrointest Endosc, 58 (2), 203-6
DOI 10.1067/mge.2003.340, PubMed 12872086

Bretthauer M, Skovlund E, Grotmol T, Thiis-Evensen E, Gondal G, Huppertz-Hauss G, Efskind P, Hofstad B, Thorp Holmsen S, Eide TJ, Hoff G (2003)
Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy screening for colorectal cancer
Scand J Gastroenterol, 38 (12), 1268-74
DOI 10.1080/00365520310006513, PubMed 14750648

Publications 2002

Bretthauer M, Hoff G, Thiis-Evensen E, Grotmol T, Holmsen ST, Moritz V, Skovlund E (2002)
Carbon dioxide insufflation reduces discomfort due to flexible sigmoidoscopy in colorectal cancer screening
Scand J Gastroenterol, 37 (9), 1103-7
DOI 10.1080/003655202320378329, PubMed 12374237

Bretthauer M, Hoff G, Thiis-Evensen E, Grotmol T, Larsen IK, Kjellevold Ø, Skovlund E (2002)
Use of a disposable sheath system for flexible sigmoidoscopy in decentralized colorectal cancer screening
Endoscopy, 34 (10), 814-8
DOI 10.1055/s-2002-34273, PubMed 12244504

Bretthauer M, Thiis-Evensen E, Huppertz-Hauss G, Gisselsson L, Grotmol T, Skovlund E, Hoff G (2002)
NORCCAP (Norwegian colorectal cancer prevention): a randomised trial to assess the safety and efficacy of carbon dioxide versus air insufflation in colonoscopy
Gut, 50 (5), 604-7
DOI 10.1136/gut.50.5.604, PubMed 11950803

Hoff G, Thiis-Evensen E, Vatn M (2002)
Screening for sporadic colorectal cancer
Endoscopy, 34 (6), 508; author reply 509-10
DOI 10.1055/s-2002-31993, PubMed 12048642

Publications 2001

Hoff G, Thiis-Evensen E, Grotmol T, Sauar J, Vatn MH, Moen IE (2001)
Do undesirable effects of screening affect all-cause mortality in flexible sigmoidoscopy programmes? Experience from the Telemark Polyp Study 1983-1996
Eur J Cancer Prev, 10 (2), 131-7
DOI 10.1097/00008469-200104000-00003, PubMed 11330453

Thiis-Evensen E (2001)
Endoscopic prevention of colorectal cancer: 13 year follow-up of the Telemark polyp study I, a prospective controlled flexible sigmoidoscopy screening study
Department of Medicine, Rikshospitalet University Hospital : Norwegian Cancer Society : Department Group for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 010548238, ISBN 82-7722-140-1

Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH (2001)
The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up
Am J Gastroenterol, 96 (6), 1901-7
DOI 10.1111/j.1572-0241.2001.03891.x, PubMed 11419846

Publications 2000

Thiis-Evensen E, Hoff GS, Sauar J, Vatn MH (2000)
Patient tolerance of colonoscopy without sedation during screening examination for colorectal polyps
Gastrointest Endosc, 52 (5), 606-10
DOI 10.1067/mge.2000.109804, PubMed 11060183

Publications 1999

Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH (1999)
Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I
Scand J Gastroenterol, 34 (4), 414-20
DOI 10.1080/003655299750026443, PubMed 10365903

Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH (1999)
Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years
Gut, 45 (6), 834-9
DOI 10.1136/gut.45.6.834, PubMed 10562581

Thiis-Evensen E, Wilhelmsen I, Hoff GS, Blomhoff S, Sauar J (1999)
The psychologic effect of attending a screening program for colorectal polyps
Scand J Gastroenterol, 34 (1), 103-9
DOI 10.1080/00365529950172916, PubMed 10048741

Publications 1997

Hoff G, Olafsson S, Thiis-Evensen E, Paulsen O, Johannesen O, Olafsson T, Hundevadt S, Sauar J (1997)
[Integration of preventive medicine in an emergency department. A pedagogic model for improvement of communication]
Tidsskr Nor Laegeforen, 117 (13), 1918-21
PubMed 9214014

Thiis-Evensen E, Hoff G, Johannesen O (1997)
[Long-term result of a life style intervention group program]
Tidsskr Nor Laegeforen, 117 (13), 1913-6
PubMed 9214013

Publications 1996

Hoff G, Sauar J, Vatn MH, Larsen S, Langmark F, Moen IE, Foerster A, Thiis-Evensen E (1996)
Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study
Scand J Gastroenterol, 31 (10), 1006-10
DOI 10.3109/00365529609003121, PubMed 8898422

Publications 1980

Kjuus H, Thiis-Evensen E, Hillestad L (1980)
[Hypertension in industrial workers. A comparative study of prevalence for the years 1959 and 1975]
Tidsskr Nor Laegeforen, 100 (13), 885-6
PubMed 7385127

Publications 1978

Hansteen IL, Hillestad L, Thiis-Evensen E, Heldaas SS (1978)
Effects of vinyl chloride in man: a cytogenetic follow-up study
Mutat Res, 51 (2), 271-8
DOI 10.1016/s0027-5107(78)80022-0, PubMed 692543

Publications 1977

Thiis-Evensen E (1977)
[Vocational rehabilitation at Porsgrunn industries]
Tidsskr Nor Laegeforen, 97 (26), 1314-5
PubMed 910221

Publications 1975

Thiis-Evensen E (1975)
[Co-operation within the industrial health service in highly industrialized areas]
Nord Med, 90 (11), 284-6
PubMed 1208200

Publications 1964

THIIS-EVENSEN E (1964)
[REHABILITATION OF INFARCT PATIENTS]
Soc Med Tidskr, 41, 26-9
PubMed 14113647

THIIS-EVENSEN E (1964)
[REHABILITATION OF INFARCT PATIENTS]
Soc Med Tidskr, SUPPL 31:25-8
PubMed 14142250

Publications 1962

THIIS-EVENSEN E (1962)
[Handicapped workers in industry. Health conditions among epileptics in the Eidanger Saltpetre Mills]
Tidsskr Nor Laegeforen, 82, 1282-4
PubMed 13980993

Publications 1958

THIIS-EVENSEN E (1958)
Shift work and health
Ind Med Surg, 27 (10), 493-7
PubMed 13586932

Publications 1957

THIIS-EVENSEN E (1957)
[Health control of adult people]
Tidsskr Nor Laegeforen, 77 (22), 992-7
PubMed 13519487

Publications 1953

THIIS-EVENSEN E (1953)
[Night work and peptic ulcer]
Nord Hyg Tidskr (3-4), 69-77
PubMed 13063750

Publications 1951

THIIS-EVENSEN E (1951)
[Shift work and health]
Nord Hyg Tidskr, 10-12, 297-312
PubMed 14919923

Publications 1948

THIIS-EVENSEN E (1948)
[Positive Meinick's reaction in healthy people]
Tidsskr Nor Laegeforen, 68 (14-15), 370
PubMed 18883726